Final Biosimilars Pathway Must Make Patient Safety and Incentives for Continued Innovation Top Priorities, Says BIO
WASHINGTON–(BUSINESS WIRE)–The following statement was issued by Sara Radcliffe, executive vice president for Health at the Biotechnology Industry Organization (BIO), who is scheduled to participate today in the U.S. Food and Drug Administration’s (FDA) Public Hearing on the Approval Pathway for Biosimilar and Interchangeable Biological Products: “BIO supported the passage of legislation to …

Read more on Business Wire

Brockton man with $17,000 water bill says city owes him, sends it a bill
Robert Ford sent the city a bill on Friday, claiming he actually paid for more water than he owed.

Read more on The Patriot Ledger

Bisping says it’s his time to shine in the UFC
Michael Bisping looks to take his brand up a notch as he faces Japanese middleweight Yoshihiro Akiyama in the main event of UFC 120 on Saturday at London’s O2 Arena.

Read more on Sportsnet.ca